Insider · CIK 0001471650

Franson Timothy R

Reports to the SEC for 3 companies · SALT LAKE CITY, UT

sec.gov

Transactions

Companies

Filings

CIK

0001471650

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-09-21	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2023-09-21	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2023-09-21	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2023-09-21	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2023-09-21	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,000 sh	—	—	0
2023-09-21	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2023-09-21	Paratek Pharmaceuticals, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−52K sh	—	—	20,000
2023-09-21	Paratek Pharmaceuticals, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2023-09-21	Paratek Pharmaceuticals, Inc.Stock option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2023-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+42.5K sh	—	—	42,500
2023-02-21	Paratek Pharmaceuticals, Inc.S Sale	Director	SSale	−7,000 sh	$1.88	−$13.2K	72,000
2023-02-08	Paratek Pharmaceuticals, Inc.A Award	Director	AAward	+20K sh	—	—	79,000
2022-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+28K sh	—	—	28,000
2022-02-16	Paratek Pharmaceuticals, Inc.A Award	Director	AAward	+20K sh	—	—	59,000
2021-09-13	CDTXCidara Therapeutics, Inc.P Purchase	Director	PPurchase	+7,000 sh	$2.12	+$14.8K	11,000
2021-06-23	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2021-02-18	Paratek Pharmaceuticals, Inc.A Award	Director	AAward	+9,000 sh	—	—	39,000
2021-02-18	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2020-06-25	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2020-02-19	Paratek Pharmaceuticals, Inc.A Award	Director	AAward	+9,000 sh	—	—	30,000
2020-02-19	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2019-06-17	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2019-02-26	Paratek Pharmaceuticals, Inc.A Award	Director	AAward	+7,500 sh	—	—	21,000
2019-02-26	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2018-06-13	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2018-02-14	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2018-02-14	Paratek Pharmaceuticals, Inc.A Award	Director	AAward	+7,500 sh	—	—	13,500
2017-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2017-02-02	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2017-02-02	Paratek Pharmaceuticals, Inc.A Award	Director	AAward	+6,000 sh	—	—	6,000
2016-06-22	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2016-02-04	Paratek Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2015-07-31	Paratek Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2015-06-09	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2015-04-20	CDTXCidara Therapeutics, Inc.P Purchase	Director	PPurchase	+4,000 sh	$16.00	+$64K	4,000
2011-12-08	Myrexis, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+16.3K sh	—	—	16,250
2010-11-11	Myrexis, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+16.3K sh	—	—	16,250

Recent filings

Accepted (ET)
Sep 214
Franson Timothy R0000899243-23-019355
SEC(opens sec.gov)
Jun 234
Franson Timothy R0001610618-23-000067
SEC(opens sec.gov)
Feb 234
Franson Timothy R0000904454-23-000176
SEC(opens sec.gov)
Feb 94
Franson Timothy R0000904454-23-000103
SEC(opens sec.gov)
Jun 244
Franson Timothy R0001610618-22-000060
SEC(opens sec.gov)
Feb 184
Franson Timothy R0000904454-22-000165
SEC(opens sec.gov)
Sep 144
Franson Timothy R0001610618-21-000084
SEC(opens sec.gov)
Jun 244
Franson Timothy R0001610618-21-000057
SEC(opens sec.gov)
Feb 224
Franson Timothy R0000904454-21-000230
SEC(opens sec.gov)
Jun 254
Franson Timothy R0001140361-20-014777
SEC(opens sec.gov)
Feb 214
Franson Timothy R0000904454-20-000244
SEC(opens sec.gov)

Companies

Address

C/O MYREXIS, INC. 305 CHIPETA WAY

SALT LAKE CITY, UT, 84108